关于 Fountain biopharma inc

关于公司

Fountain Biopharma, a subsidiary company of Microbio Co., Ltd., founded in December 2010 in Taiwan, focus on development of therapeutic monoclonal antibodies and DNA aptamers for cancer and immunological conditions, aiming to meet unmet medical needs with innovation. Fountain has instituted several key platform technologies for novel drug development including Cancer stem cell culture technology, IgE platform technology, fully human antibody library, high throughput aptatmer screening technology, high yield cell line development, upstream/downstream manufacturing process development, analytical methods development and ILAC/TAF certified animal facility. Pipelines and key technologies are strengthened by collaboration with several leading academic institutes. Fountain has 7 pipelines in clinical and pre-clinical stages. Global drug development strategy and well positioned as a platform to enter into Asia Pacific markets make Fountain to be a great partner in the development of antibody/aptamer therapeutics.